Advertisement

Topics

Lilly Adds Chemistry Capabilities in San Diego Lab Expansion

18:41 EDT 22 Jun 2017 | Xconomy

Eli Lilly (NYSE: LLY) has completed a $90 million expansion of its biotechnology R&D center in San Diego, added new automated synthesis equipment, and plans to build out its next-generation chemistry capabilities here over the next two years. The new facility adds 180,000 square feet of space to Lilly’s laboratory in La Jolla—a 145 percent […]

Original Article: Lilly Adds Chemistry Capabilities in San Diego Lab Expansion

NEXT ARTICLE

More From BioPortfolio on "Lilly Adds Chemistry Capabilities in San Diego Lab Expansion"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...